TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

70 hedge funds and large institutions have $34M invested in Theriva Biologics in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more funds holding in top 10

Funds holding in top 10: →

0% less ownership

Funds ownership: 0% → 0% (-0%)

44% less capital invested

Capital invested by funds: $60.8M → $34M (-$26.8M)

Holders
70
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$7.97M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.5M
2
+$2.31M
3
+$767K
4
UOC
UBS O'Connor
Illinois
+$763K
5
Millennium Management
Millennium Management
New York
+$576K

Top Sellers

1
-$1.29M
2
-$742K
3
-$267K
4
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$131K
5
RCP
Rothschild Capital Partners
New York
-$52K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$128K
27
$125K
28
$102K
29
$96K
30
$92K
31
$91K
32
$82K
33
$77K
34
$76K
35
$76K
36
$75K
37
$67K
38
$67K
39
$65K
40
$46K
41
$36K
42
$35K
43
$33K
44
$33K
45
$33K
46
$29K
47
$29K
48
$29K
49
$27K
50
$26K
1
2
3 4